Published in Tob Control on December 01, 2004
Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer (2009) 3.14
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Tobacco use in sub-Sahara Africa: estimates from the demographic health surveys. Soc Sci Med (2008) 2.03
Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis (2012) 1.87
A novel evaluation of World No Tobacco day in Latin America. J Med Internet Res (2012) 1.73
Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl) (2005) 1.62
Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tob Control (2007) 1.50
The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord (2009) 1.46
Prevalence, distribution and correlates of tobacco smoking and chewing in Nepal: a secondary data analysis of Nepal Demographic and Health Survey-2006. Subst Abuse Treat Prev Policy (2011) 1.25
Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol (2008) 1.17
Gender and locality differences in tobacco prevalence among adult Bangladeshis. Tob Control (2009) 1.17
Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control (2010) 1.11
Self-reported use of tobacco products in nine rural INDEPTH Health and Demographic Surveillance Systems in Asia. Glob Health Action (2009) 1.08
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol (2011) 1.05
The costs of smoking in Vietnam: the case of inpatient care. Tob Control (2007) 1.03
Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One (2010) 1.02
Prevalence and correlates of smoking among urban adult men in Bangladesh: slum versus non-slum comparison. BMC Public Health (2009) 1.00
Epidemiology of ischaemic heart disease in sub-Saharan Africa. Cardiovasc J Afr (2013) 0.94
Methodologies used to estimate tobacco-attributable mortality: a review. BMC Public Health (2008) 0.92
Prevalence and correlates of smokeless tobacco consumption among married women in rural Bangladesh. PLoS One (2014) 0.90
The Epithelial Cell in Lung Health and Emphysema Pathogenesis. Curr Respir Med Rev (2006) 0.90
Mortality attributable to cigarette smoking in a cohort study in Japan. Eur J Epidemiol (2007) 0.89
Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J (2012) 0.89
Rural-urban differentials of premature mortality burden in south-west China. Int J Equity Health (2006) 0.88
Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. Cancer Epidemiol Biomarkers Prev (2009) 0.87
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis. BMC Clin Pharmacol (2011) 0.85
Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci (2015) 0.84
Does smoking among friends explain apparent genetic effects on current smoking in adolescence and young adulthood? Br J Cancer (2008) 0.82
Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease. Med J Islam Repub Iran (2014) 0.78
Impact of smoking on mortality of patients with non-small cell lung cancer. Thorac Cancer (2014) 0.77
Prevalence of Smokeless Tobacco among Low Socioeconomic Populations: A Cross-Sectional Analysis. PLoS One (2016) 0.77
Socioeconomic patterning in tobacco use in Argentina, 2005. Nicotine Tob Res (2011) 0.77
Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. Open Forum Infect Dis (2016) 0.77
Tobacco-stained fingers: a clue for smoking-related disease or harmful alcohol use? A case-control study. BMJ Open (2013) 0.77
Proportion of Mortality Attributable to Tobacco Worldwide. Iran J Public Health (2016) 0.75
The impact of smoking on gender differences in life expectancy: more heterogeneous than often stated. Eur J Public Health (2014) 0.75
Exploring cigarette use among male migrant workers in Nigeria. Int J Health Policy Manag (2015) 0.75
Community-Based Screening, Brief Intervention, and Referral for Treatment for Unhealthy Tobacco Use: Single Arm Study Experience and Implementation Success in Rural and Semi-Rural Settings, South-West Nigeria. Front Psychiatry (2016) 0.75
Smokeless tobacco consumption impedes metabolic, cellular, apoptotic and systemic stress pattern: A study on Government employees in Kolkata, India. Sci Rep (2015) 0.75
Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE). BMC Public Health (2011) 0.75
Pre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article. Medicine (Baltimore) (2016) 0.75
Trend analysis of hospital admissions attributable to tobacco smoking, Northern Territory Aboriginal and non-Aboriginal populations, 1998 to 2009. BMC Public Health (2012) 0.75
Prevalence and Pattern of Smoking among Bus Drivers of Dhaka, Bangladesh. Tob Use Insights (2014) 0.75
Toxicity of Smokeless Tobacco Extract after 184-Day Repeated Oral Administration in Rats. Int J Environ Res Public Health (2016) 0.75
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ (1997) 7.37
Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet (2003) 6.58
Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94
Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst (2002) 3.45
Risk attribution and tobacco-related deaths. Am J Epidemiol (1993) 3.41
Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA (2000) 3.21
Smoking and mortality among older men and women in three communities. N Engl J Med (1991) 2.86
Methodological issues in estimating smoking-attributable mortality in the United States. Am J Epidemiol (2000) 1.50
Mortality from tobacco in developed countries: are indirect estimates reliable? Regul Toxicol Pharmacol (1996) 0.91
Tobacco and the Commonwealth: a call to action. Lancet (2003) 0.89
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94
Armed conflict as a public health problem. BMJ (2002) 4.42
Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31
On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66
The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46
Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37
Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17
The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84
The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49
Measuring the burden of disease. Lancet (1998) 1.58
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Hypertension in developing countries. World Health Stat Q (1988) 1.45
Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35
Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33
Tobacco or health. World Health Stat Q (1993) 1.32
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19
Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
On the assessment of maternal mortality. World Health Stat Q (1987) 1.04
A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02
Sex differentials in mortality. WHO Chron (1984) 1.02
Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00
Reducing child mortality. Bull World Health Organ (2000) 0.94
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92
Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91
Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89
Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88
Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86
Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85
Smoking and death in Russia. Tob Control (1998) 0.84
A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83
Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83
The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81
Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81
Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80
Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80
100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79
Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79
Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78
Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78
Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77
Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77
Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77
Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76
In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76
Investigating Australia's burden of disease. Med J Aust (2000) 0.75
Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75
The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75
Health projections. Introduction. World Health Stat Q (1984) 0.75
Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75
Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75
Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75
Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75
[Preventable deaths: general view]. World Health Stat Q (1989) 0.75